Hosted on MSN
Colossal Biosciences Acquires Cloning Company Viagen: How It Advances De-Extinction and Conservation (Exclusive)
Colossal Biosciences has announced its first acquisition, bringing Viagen Pets and Equine, the world leader in animal cloning, into its growing biotechnology family. Viagen made headlines a few years ...
Scientists across the globe are working to bring extinct species back to life. But do the facts measure up, or is this still ...
The term “de-extinction” often conjures images of Jurassic Park-style genetic manipulation, complete with ethical dilemmas and ecological chaos. But the reality of functional de-extinction—the ...
Over the past week, the media have been inundated with news of the "de-extinction" of the dire wolf (Aenocyon dirus)—a species that went extinct about 13,000 years ago. The breakthrough has been ...
Knoepfler is STAT’s Lab Dish columnist and a professor of cell biology and human anatomy at UC Davis School of Medicine. De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring ...
Efforts to revive the thylacine and woolly mammoth are forcing conservationists to face a long-overdue debate over what kind ...
Benjamin holds a Master's degree in anthropology from University College London and has previously worked in the fields of psychedelic neuroscience and mental health. Benjamin holds a Master's degree ...
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s only de-extinction company, today announces the rebirth of the once extinct dire wolf, the world’s first successfully de-extincted animal.
As the Trump administration slashes funding for health, energy and climate research, there’s one science the administration is promoting: de-extinction. Earlier this month, a biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results